Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls
Giulia Cisbani, Serge Rivest
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5504-5515
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
Daniela Lecca, Yoo Jin Jung, Michael T. Scerba, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 11, pp. 2327-2340
Open Access | Times Cited: 124
Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
Yanting Chen, Yanfang He, Jinling Han, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Gilbert Ogunmokun, Saikat Dewanjee, Pratik Chakraborty, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2790-2790
Open Access | Times Cited: 52
Mind the Gap: Unraveling the Intricate Dance Between Alzheimer’s Disease and Related Dementias and Bone Health
Sonali Karnik, Tyler J. Margetts, Hannah S. Wang, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 165-176
Open Access | Times Cited: 6
Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system
Vera Fominykh, Alexey Shadrin, Piotr Jahołkowski, et al.
Neurobiology of Disease (2023) Vol. 183, pp. 106174-106174
Open Access | Times Cited: 14
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells
Beatrice Polini, Lorenzo Zallocco, Francesca Gado, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 875-875
Open Access | Times Cited: 5
Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia
Minjia Mo, Maria Eriksdotter, Sofia Ajeganova, et al.
Neurology (2025) Vol. 104, Iss. 5
Closed Access
Identification of biomarkers in Alzheimer’s disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms
Juntu Li, Linfeng Tao, Yanyou Zhou, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317915-e0317915
Open Access
Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer’s Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis
Abdalla Bowirrat
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1817-1817
Open Access | Times Cited: 21
Passive Immunotherapies Targeting Amyloid-βin Alzheimer’s Disease: A Quantitative Systems Pharmacology Perspective
Milica Marković, Jelica Milošević, Weirong Wang, et al.
Molecular Pharmacology (2023) Vol. 105, Iss. 1, pp. 1-13
Open Access | Times Cited: 12
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
Beatrice Polini, Caterina Ricardi, A Bertolini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11569-11569
Open Access | Times Cited: 11
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
Janna I.R. Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 3
Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease
Andreana Benitez, Jens H. Jensen, Kathryn E. Thorn, et al.
Annals of Neurology (2022) Vol. 91, Iss. 6, pp. 864-877
Open Access | Times Cited: 14
Fabrication of a polymer brush-functionalized porphyrin-based covalent organic framework for enrichment of N-glycopeptides
Bing Wang, Xiaoya Zhang, Shuwen Hua, et al.
Microchimica Acta (2023) Vol. 191, Iss. 1
Closed Access | Times Cited: 8
Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1
Qingqing Xu, Ziren Su, Zhen Hu, et al.
Phytomedicine (2022) Vol. 106, pp. 154441-154441
Closed Access | Times Cited: 13
Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
Qing‐Qing Tao, Rong-Rong Lin, Yi-He Chen, et al.
Aging and Disease (2022) Vol. 13, Iss. 5, pp. 1391-1391
Open Access | Times Cited: 13
Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease
Xian‐Le Bu, Pu‐Yang Sun, Dong‐Yu Fan, et al.
Science Advances (2022) Vol. 8, Iss. 13
Closed Access | Times Cited: 12
Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease
Mei-Yun Tang, Fredric A. Gorin, Pamela J. Lein
Ageing and Neurodegenerative Diseases (2022)
Open Access | Times Cited: 11
Identification of Immune Hub Genes Associated With Braak Stages in Alzheimer’s Disease and Their Correlation of Immune Infiltration
Xiaohang Qian, Xiaoli Liu, Shengdi Chen, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 9
Role of inflammation in the socioeconomic inequalities of neurocognitive disorders
Aswathikutty Gireesh, Amanda Sacker, Anne McMunn, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 203-211
Open Access | Times Cited: 5
Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer's disease
Ashwini Gawade, Satish Polshettiwar, Hetal Hingalajia, et al.
Elsevier eBooks (2024), pp. 391-402
Closed Access | Times Cited: 1
CD36-mediated ROS/PI3K/AKT signaling pathway exacerbates cognitive impairment in APP/PS1 mice after noise exposure
Zan Zhou, Wenjun Jiang, Yanping Wang, et al.
The Science of The Total Environment (2024) Vol. 952, pp. 175879-175879
Closed Access | Times Cited: 1
Microglia‐derived Galectin‐9 drives amyloid‐β pathology in Alzheimer's disease
Guoxin Zhang, Qinyu Peng, Xiaodi Guo, et al.
Aging Cell (2024)
Open Access | Times Cited: 1
Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis
Pierre-Alexandre Piec, Vincent Pons, Serge Rivest
Cells (2021) Vol. 10, Iss. 8, pp. 2164-2164
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top